| LOSS PER COMMON SHARE |
LOSS PER COMMON SHARE The following table sets forth the components used in the computation of basic and diluted loss per share for the three months ended May 31, 2026 and 2025:
| | | | | | | | | | | | | | | | (In thousands, except share and per share data) | | Three Months Ended May 31, 2026 | | Three Months Ended May 31, 2025 | | Basic loss per share: | | | | | | Numerator: | | | | | | Net loss | | $ | (83,595) | | | $ | (623) | | | | | | | | | | | | | Net loss available to common stockholders - basic | | $ | (83,576) | | | $ | (623) | | | | | | | | Denominator: | | | | | | Weighted average common shares outstanding - basic | | 551,788,656 | | 2,006,202 | | Basic loss per common share | | $ | (0.15) | | | $ | (0.31) | | | | | | | | Diluted loss per share: | | | | | | Numerator: | | | | | | Net loss available to common stockholders - diluted | | $ | (83,576) | | | $ | (623) | | | Denominator: | | | | | | Weighted average common shares outstanding - basic | | 551,788,656 | | 2,006,202 | | Add: dilutive securities | | 0 | | 0 | | Warrants | | 0 | | 0 | | RSAs | | 0 | | 0 | | Weighted average common shares outstanding - diluted | | 551,788,656 | | 2,006,202 | | Diluted loss per common share | | $ | (0.15) | | | $ | (0.31) | |
The following table sets forth the components used in the computation of basic and diluted loss per share for the nine months ended May 31, 2026 and 2025:
| | | | | | | | | | | | | | | | (In thousands, except share and per share data) | | Nine Months Ended May 31, 2026 | | Nine Months Ended May 31, 2025 | | Basic loss per share: | | | | | | Numerator: | | | | | | Net loss | | $ | (9,106,103) | | | $ | (2,754) | | | | | | | | | | | | | Net loss available to common stockholders - basic | | $ | (9,106,084) | | | $ | (5,715) | | | | | | | | Denominator: | | | | | | Weighted average common shares outstanding - basic | | 443,947,604 | | 2,185,206 | | Basic loss per common share | | $ | (20.51) | | | $ | (2.62) | | | | | | | | Diluted loss per share: | | | | | | Numerator: | | | | | | Net loss available to common stockholders - diluted | | $ | (9,106,084) | | | $ | (5,715) | | | Denominator: | | | | | | Weighted average common shares outstanding - basic | | 443,947,604 | | 2,185,206 | | Add: dilutive securities | | 0 | | 0 | | Warrants | | 0 | | 0 | | RSAs | | 0 | | 0 | | Weighted average common shares outstanding - diluted | | 443,947,604 | | 2,185,206 | | Diluted loss per common share | | $ | (20.51) | | | $ | (2.62) | |
The following table summarizes the securities that were not included in the computation of diluted income per common share because their effect is anti-dilutive:
| | | | | | | | | | | | | | | | | Outstanding as of | | Outstanding as of | | | May 31, 2026 | | May 31, 2025 | C-3 Warrants(1) | | 1,280 | | 1,280 | Strategic Advisor Warrants(1) | | 2,820,774 | | 0 | Representative Warrants(1) | | 50,875 | | 0 | CVI Warrants(2) | | 10,435,430 | | 0 | Options(1) & (2) | | 359,124 | | 0 | Performance-based RSUs(3) | | 4,500,000 | | 0 | RSAs (1) | | 0 | | 135,360 |
| | | (1) 302,124 Options, RSAs ,Strategic and Representative Warrants were excluded due to a net loss position during the reporting periods | (2) C-3 Warrants, CVI Warrants and 57,000 Options were out-of-money during the three and nine months ended May 31, 2026 | (3) The performance-based RSUs have certain stock price, market cap and other market/performance conditions which were not met as of May 31, 2026. |
|